{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T17:41:32Z","timestamp":1789148492939,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100003329","name":"Ministerio de Economia y Competitividad","doi-asserted-by":"crossref","award":["SAF2011-23475"],"award-info":[{"award-number":["SAF2011-23475"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Alianza VHL Spain","award":["ID0EXZAG448"],"award-info":[{"award-number":["ID0EXZAG448"]}]},{"name":"Fundaci\u00f3n Iberdrola","award":["ID0E61AG449"],"award-info":[{"award-number":["ID0E61AG449"]}]},{"name":"Fundaci\u00f3n Divina Pastora","award":["ID0EH3AG450"],"award-info":[{"award-number":["ID0EH3AG450"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13023-015-0343-5","type":"journal-article","created":{"date-parts":[[2015,9,22]],"date-time":"2015-09-22T08:25:03Z","timestamp":1442910303000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Propranolol reduces viability and induces apoptosis in hemangioblastoma cells from von Hippel-Lindau patients"],"prefix":"10.1186","volume":"10","author":[{"given":"Virginia","family":"Albi\u00f1ana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina","family":"Villar G\u00f3mez de las Heras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Serrano-Heras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom\u00e1s","family":"Segura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Bel\u00e9n","family":"Perona-Moratalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Mota-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Mar\u00eda","family":"de Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa Mar\u00eda","family":"Botella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,9,22]]},"reference":[{"key":"343_CR1","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/ejhg.2010.175","volume":"19","author":"ER Maher","year":"2011","unstructured":"Maher ER, Neumann HP, Richard S. Von Hippel-Lindau disease: a clinical and scientific review. Eur J Hum Genet. 2011;19:617\u201323.","journal-title":"Eur J Hum Genet"},{"issue":"1","key":"343_CR2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.semcancer.2012.05.005","volume":"23","author":"S Richard","year":"2013","unstructured":"Richard S, Gardie B, Couv\u00e9 S, Gad S. Von Hippel-Lindau: how a rare disease illuminates cancer biology. Semin Cancer Biol. 2013;23(1):26\u201337.","journal-title":"Semin Cancer Biol"},{"issue":"9","key":"343_CR3","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrc885","volume":"2","author":"WG Kaelin Jr","year":"2002","unstructured":"Kaelin Jr WG. Molecular basis of the VHL hereditary cancer syndrome. Nat Rev Cancer. 2002;2(9):673\u201382.","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"343_CR4","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/nrc2502","volume":"8","author":"WG Kaelin Jr","year":"2008","unstructured":"Kaelin Jr WG. The von Hippel-Lindau tumor suppressor protein: O2 sensing and cancer. Nat Rev Cancer. 2008;8(11):865\u201373.","journal-title":"Nat Rev Cancer"},{"issue":"9","key":"343_CR5","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nrneph.2013.144","volume":"9","author":"B Bausch","year":"2013","unstructured":"Bausch B, Jilg C, Gl\u00e4sker S, Vortmeyer A, L\u00fctzen N, Anton A, et al. Renal cancer in von Hippel-Lindau disease and related syndromes. Nat Rev Nephrol. 2013;9(9):529\u201338.","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"343_CR6","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00401-013-1091-z","volume":"125","author":"AO Vortmeyer","year":"2013","unstructured":"Vortmeyer AO, Falke EA, Gl\u00e4sker S, Li J, Oldfield EH. Nervous system involvement in von Hippel-Lindau disease: pathology and mechanisms. Acta Neuropathol. 2013;125(3):333\u201350.","journal-title":"Acta Neuropathol"},{"issue":"5","key":"343_CR7","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1136\/jnnp.70.5.644","volume":"70","author":"S Gl\u00e4sker","year":"2001","unstructured":"Gl\u00e4sker S, Bender BU, Apel TW, van Velthoven V, Mulligan LM, Zentner J, et al. Reconsideration of biallelic inactivation of the VHL tumor suppressor gene in hemangioblastomas of the central nervous system. J Neurol Neurosurg Psychiatry. 2001;70(5):644\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"11","key":"343_CR8","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/j.febslet.2012.04.032","volume":"586","author":"HL Bader","year":"2012","unstructured":"Bader HL, Hsu T. Systemic VHL gene functions and the VHL disease. FEBS Lett. 2012;586(11):1562\u20139.","journal-title":"FEBS Lett"},{"issue":"5\u20136","key":"343_CR9","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3109\/08820538.2013.825281","volume":"28","author":"NM Haddad","year":"2013","unstructured":"Haddad NM, Cavallerano JD, Silva PS. Von hippel-lindau disease: a genetic and clinical review. Semin Ophthalmol. 2013;28(5\u20136):377\u20138.","journal-title":"Semin Ophthalmol"},{"issue":"7","key":"343_CR10","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.jocn.2013.10.023","volume":"21","author":"CD Kassardjian","year":"2014","unstructured":"Kassardjian CD, Macdonald RL, Munoz DG. Hemangioblastomas in the elderly: epidemiology and clinical characteristics. J Clin Neurosci. 2014;21(7):1205\u20138.","journal-title":"J Clin Neurosci"},{"key":"343_CR11","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.ad.2011.05.003","volume":"102","author":"I Sanchez-Carpintero","year":"2011","unstructured":"Sanchez-Carpintero I, Ruiz-Rodrig R, Lopez-Gutierrez JC. propranolol in the treatment of infantile hemangioma: clinical effectiveness, risks, and recommendations. Actas Dermosifiliogr. 2011;102:766\u201379.","journal-title":"Actas Dermosifiliogr"},{"issue":"8","key":"343_CR12","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1056\/NEJMoa1404710","volume":"372","author":"C L\u00e9aut\u00e9-Labr\u00e8ze","year":"2015","unstructured":"L\u00e9aut\u00e9-Labr\u00e8ze C, Hoeger P, Mazereeuw-Hautier J, Guibaud L, Baselga E, Posiunas G, et al. A randomized, controlled trial of oral propranolol in infantile hemangioma. N Engl J Med. 2015;372(8):735\u201346.","journal-title":"N Engl J Med"},{"key":"343_CR13","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1365-2133.2010.09848.x","volume":"163","author":"CH Storch","year":"2010","unstructured":"Storch CH, Hoeger PH. propranolol for infantile haemangiomas: insights into the molecular mechanisms of action. Br J Dermatol. 2010;163:269\u201374.","journal-title":"Br J Dermatol"},{"key":"343_CR14","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.vph.2010.08.002","volume":"53","author":"S Lamy","year":"2010","unstructured":"Lamy S, Lachambre MP, Lord-Dufour S, B\u00e9liveau R. propranolol suppresses angiogenesis in vitro: inhibition of proliferation, migration, and differentiation of endothelial cells. Vasc Pharmacol. 2010;53:200\u20138.","journal-title":"Vasc Pharmacol"},{"key":"343_CR15","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1056\/NEJMc0708819","volume":"358","author":"C Leaute-Labreze","year":"2008","unstructured":"Leaute-Labreze C, de la Dumas Roque E, Hubiche T, Boralevi F, Thambo JB, Ta\u00efeb A. propranolol for severe hemangiomas of infancy. N Engl J Med. 2008;358:2649\u201351.","journal-title":"N Engl J Med"},{"issue":"1","key":"343_CR16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1160\/TH11-11-0809","volume":"108","author":"V Albi\u00f1ana","year":"2012","unstructured":"Albi\u00f1ana V, Recio-Poveda L, Zarrabeitia R, Bernab\u00e9u C, Botella LM. propranolol as antiangiogenic candidate for the therapy of hereditary haemorrhagic telangiectasia. Thromb Haemost. 2012;108(1):41\u201353.","journal-title":"Thromb Haemost"},{"issue":"1","key":"343_CR17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.bbrc.2013.07.028","volume":"438","author":"VK Ponnaluri","year":"2013","unstructured":"Ponnaluri VK, Vavilala DT, Prakash S, Mukherji M. Hypoxia mediated expression of stem cell markers in VHL-associated hemangioblastomas. Biochem Biophys Res Commun. 2013;438(1):71\u20137.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"343_CR18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0002-9440(10)65541-1","volume":"153","author":"I Flamme","year":"1998","unstructured":"Flamme I, Krieg M, Plate KH. Up-regulation of vascular endothelial growth factor in stromal cells of hemangioblastomas is correlated with up-regulation of the transcription factor HRF\/HIF-2alpha. Am J Pathol. 1998;153(1):25\u20139.","journal-title":"Am J Pathol"},{"issue":"2","key":"343_CR19","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.yexmp.2013.12.011","volume":"96","author":"S Gl\u00e4sker","year":"2014","unstructured":"Gl\u00e4sker S, Smith J, Raffeld M, Li J, Oldfield EH, Vortmeyer AO. VHL-deficient vasculogenesis in hemangioblastoma. Exp Mol Pathol. 2014;96(2):162\u20137.","journal-title":"Exp Mol Pathol"},{"key":"343_CR20","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1290\/1071-2690(2002)038<0298:BBIAIC>2.0.CO;2","volume":"38","author":"SK Sommers Smith","year":"2002","unstructured":"Sommers Smith SK, Smith DM. Beta blockade induces apoptosis in cultured capillary endothelial cells. In Vitro Cell Dev Biol Anim. 2002;38:298\u2013304.","journal-title":"In Vitro Cell Dev Biol Anim"},{"issue":"283","key":"343_CR21","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1093\/qjmed\/77.2.1151","volume":"77","author":"ER Maher","year":"1990","unstructured":"Maher ER, Yates JR, Harries R, Benjamin C, Harris R, Moore AT, et al. Clinical features and natural history of von Hippel-Lindau disease. Q J Med. 1990;77(283):1151\u201363.","journal-title":"Q J Med"},{"issue":"9374","key":"343_CR22","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(03)13643-4","volume":"361","author":"RR Lonser","year":"2003","unstructured":"Lonser RR, Glenn GM, Walther M, Chew EY, Libutti SK, Linehan WM, et al. Von Hippel-Lindau disease. Lancet. 2003;361(9374):2059\u201367.","journal-title":"Lancet"},{"issue":"4","key":"343_CR23","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1073\/pnas.68.4.820","volume":"68","author":"AG Knudson Jr","year":"1971","unstructured":"Knudson Jr AG. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A. 1971;68(4):820\u20133.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"343_CR24","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0046-8177(97)90075-7","volume":"28","author":"AO Vortmeyer","year":"1997","unstructured":"Vortmeyer AO, Gnarra JR, Emmert-Buck MR, Katz D, Linehan WM, Oldfield EH, et al. Von Hippel-Lindau gene deletion detected in the stromal cell component of a cerebellar hemangioblastoma associated with von Hippel-Lindau disease. Hum Pathol. 1997;28(5):540\u20133.","journal-title":"Hum Pathol"},{"key":"343_CR25","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1101\/sqb.2011.76.010678","volume":"76","author":"GL Semenza","year":"2011","unstructured":"Semenza GL. Regulation of metabolism by hypoxia-inducible factor 1. Cold Spring Harb Symp Quant Biol. 2011;76:347\u201353.","journal-title":"Cold Spring Harb Symp Quant Biol"},{"issue":"5","key":"343_CR26","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1124\/mol.106.027029","volume":"70","author":"Q Ke","year":"2006","unstructured":"Ke Q, Costa M. Hypoxia-inducible factor-1 (HIF-1). Mol Pharmacol. 2006;70(5):1469\u201380.","journal-title":"Mol Pharmacol"},{"issue":"2","key":"343_CR27","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1182\/blood-2004-07-2958","volume":"105","author":"DJ Manalo","year":"2005","unstructured":"Manalo DJ, Rowan A, Lavoie T, Natarajan L, Kelly BD, Ye SQ, et al. Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. Blood. 2005;105(2):659\u201369.","journal-title":"Blood"},{"issue":"5","key":"343_CR28","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1097\/PAS.0b013e3181967992","volume":"33","author":"M P\u00e9rigny","year":"2009","unstructured":"P\u00e9rigny M, Hammel P, Corcos O, Larochelle O, Giraud S, Richard S, et al. Pancreatic endocrine microadenomatosis in patients with von Hippel-Lindau disease: characterization by VHL\/HIF pathway proteins expression. Am J Surg Pathol. 2009;33(5):739\u201348.","journal-title":"Am J Surg Pathol"},{"issue":"Suppl 1","key":"343_CR29","doi-asserted-by":"crossref","first-page":"S119","DOI":"10.1097\/SAP.0000000000000272","volume":"73","author":"RW England","year":"2014","unstructured":"England RW, Hardy KL, Kitajewski AM, Wong A, Kitajewski JK, Shawber CJ, et al. propranolol promotes accelerated and dysregulated adipogenesis in hemangioma stem cells. Ann Plast Surg. 2014;73 Suppl 1:S119\u201324.","journal-title":"Ann Plast Surg"},{"issue":"5","key":"343_CR30","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1097\/PRS.0b013e318267d3db","volume":"130","author":"A Wong","year":"2012","unstructured":"Wong A, Hardy KL, Kitajewski AM, Shawber CJ, Kitajewski JK, Wu JK. Propranolol accelerates adipogenesis in hemangioma stem cells and causes apoptosis of hemangioma endothelial cells. Plast Reconstr Surg. 2012;130(5):1012\u201321.","journal-title":"Plast Reconstr Surg"},{"issue":"1","key":"343_CR31","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/bjd.13379","volume":"172","author":"A Langley","year":"2015","unstructured":"Langley A, Pope E. Propranolol and central nervous system function: potential implications for paediatric patients with infantile haemangiomas. Br J Dermatol. 2015;172(1):13\u201323.","journal-title":"Br J Dermatol"},{"issue":"3","key":"343_CR32","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1056\/NEJMc1503811","volume":"373","author":"A Tozzi","year":"2015","unstructured":"Tozzi A. Oral Propranolol for Infantile Hemangioma. N Engl J Med. 2015;373(3):284.","journal-title":"N Engl J Med"},{"issue":"3","key":"343_CR33","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1056\/NEJMc1503811","volume":"373","author":"C L\u00e9aut\u00e9-Labr\u00e8ze","year":"2015","unstructured":"L\u00e9aut\u00e9-Labr\u00e8ze C, Voisard JJ, Moore N. Oral Propranolol for Infantile Hemangioma. N Engl J Med. 2015;373(3):284\u20135.","journal-title":"N Engl J Med"},{"issue":"4","key":"343_CR34","first-page":"1049","volume":"11","author":"S Wizigmann-Voos","year":"1996","unstructured":"Wizigmann-Voos S, Plate KH. Pathology, genetics and cell biology of hemangioblastomas. Histol Histopathol. 1996;11(4):1049\u201361.","journal-title":"Histol Histopathol"},{"issue":"1","key":"343_CR35","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1006\/bcmd.2002.0488","volume":"28","author":"SO Ang","year":"2002","unstructured":"Ang SO, Chen H, Gordeuk VR, Sergueeva AI, Polyakova LA, Miasnikova GY, et al. Endemic polycythemia in Russia: mutation in the VHL gene. Blood Cells Mol Dis. 2002;28(1):57\u201362.","journal-title":"Blood Cells Mol Dis"},{"issue":"5","key":"343_CR36","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1182\/blood-2003-07-2550","volume":"103","author":"E Liu","year":"2004","unstructured":"Liu E, Percy MJ, Amos CI, Guan Y, Shete S, Stockton DW, et al. The worldwide distribution of the VHL 598C\u2009>\u2009T mutation indicates a single founding event. Blood. 2004;103(5):1937\u201340.","journal-title":"Blood"},{"issue":"7","key":"343_CR37","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1182\/blood-2013-01-478065","volume":"122","author":"K Franke","year":"2013","unstructured":"Franke K, Gassmann M, Wielockx B. Erythrocytosis: the HIF pathway in control. Blood. 2013;122(7):1122\u20138.","journal-title":"Blood"},{"issue":"3","key":"343_CR38","first-page":"504","volume":"58","author":"JY Lee","year":"1998","unstructured":"Lee JY, Dong SM, Park WS, Yoo NJ, Kim CS, Jang JJ, et al. Loss of heterozygosity and somatic mutations of the VHL tumor suppressor gene in sporadic cerebellar hemangioblastomas. Cancer Res. 1998;58(3):504\u20138.","journal-title":"Cancer Res"},{"issue":"4","key":"343_CR39","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/path.2435","volume":"216","author":"SB Shively","year":"2008","unstructured":"Shively SB, Beltaifa S, Gehrs B, Duong H, Smith J, Edwards NA, et al. Protracted haemangioblastic proliferation and differentiation in von Hippel-Lindau disease. J Pathol. 2008;216(4):514\u201320.","journal-title":"J Pathol"},{"issue":"3","key":"343_CR40","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/path.2062","volume":"210","author":"AO Vortmeyer","year":"2006","unstructured":"Vortmeyer AO, Tran MG, Zeng W, Gl\u00e4sker S, Riley C, Tsokos M, et al. Evolution of VHL tumourigenesis in nerve root tissue. J Pathol. 2006;210(3):374\u201382.","journal-title":"J Pathol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-015-0343-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T17:14:40Z","timestamp":1567185280000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ojrd.com\/content\/10\/1\/118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,22]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["343"],"URL":"https:\/\/doi.org\/10.1186\/s13023-015-0343-5","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,22]]},"article-number":"118"}}